International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Longitudinal Clinical Follow-up of a Patient with Stage IV Non-Small Cell Lung Cancer Receiving Structured Fasting-Based Metabolic Therapy During Standard Oncologic Treatment: A CARE Case Report
| Author(s) | Dr Kavitha P S, Dr Ramana V Krishnan |
|---|---|
| Country | India |
| Abstract | Cancer cachexia is a multifactorial syndrome characterized by progressive loss of skeletal muscle mass, involuntary weight loss, anorexia, metabolic dysfunction, and systemic inflammation. It affects approximately 50–80% of patients with advanced malignancies and is particularly common in advanced non-small cell lung cancer (NSCLC), where it negatively influences treatment tolerance, quality of life, functional performance, and overall survival. Supportive metabolic interventions capable of improving nutritional status and physiological resilience remain inadequately studied. Structured fasting has recently emerged as a potential adjunctive metabolic strategy aimed at improving metabolic flexibility, reducing treatment-associated metabolic stress, enhancing insulin sensitivity, and preserving physiological function during cancer therapy. Long-term clinical observations documenting structured fasting introduced proactively, ahead of chemotherapy, and sustained throughout treatment remain scarce. We report the extended longitudinal follow-up of a patient with Stage IV NSCLC who began a structured one-meal-a-day (OMAD) fasting protocol as a deliberate component of his care approximately one month before starting chemotherapy, continued this protocol throughout chemotherapy and beyond, and who nonetheless experienced a period of severe chemotherapy-associated metabolic deterioration and cachexia before achieving sustained recovery. |
| Keywords | Cancer , trigonellin, Omad , fasting |
| Field | Biology |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-07-26 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals